Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Li Website

Wenqing Li, Ph.D.

Portait Photo of Wenqing Li
Laboratory of Molecular Immunoregulation
Immunological Cytokine Group
Staff Scientist
Center for Cancer Research
National Cancer Institute
Bldg. 560 /Rm. 31-46
P.O. Box B
Frederick, MD 21702-1201
Phone:  
301-846-6977
Fax:  
Fax Number not listed
E-Mail:  
liwenq@mail.nih.gov

Biography

Dr. Li received her B.S. and M.S. in biochemistry from Zhongshan (Sun Yat-sen) University, China and obtained her Ph. D in biomedical sciences from the University of Montreal. In 2001, she joined the Laboratory of Molecular Immunoregulation under Dr. Scott Durum working on the molecular mechanisms of IL-7 in T cell development and homeostasis. She was a postdoctoral and research fellow before becoming the staff scientist at NCI-Frederick.

Research

Dr. Li's research goal is to understand the intracellular pathways related to the IL-7 effects on T cell apoptosis and proliferation. She found that IL-7 promotes T cell survival and division by blocking degradation of Mcl-1 and inducing degradation of the cell cycle inhibitor p27kip1. Her current work is focused on identifying the ubiquitination pathways that IL-7 controls the stability of Mcl-1 and p27kip1 in T cells. The same pathways used by IL-7 may be preempted in carcinogenesis, since Mcl-1 is an oncogene and p27kip1 is a tumor suppressor.

This page was last updated on 3/31/2014.